To formulate and evaluate time dependent pulsatile drug delivery
system of Montelukast sodium to deliver the drug with biological
rhythm of asthma after predetermined lag time 5:30 hours. In
preliminary study, The core tablet of Montelukast sodium was
prepared by using direct compression method containing SSG,
Croscarmellose sodium, Crospovidone, MCC and Starcap1500 to obtain
fast disintegrating tablet for the selection of super
disintegrating agent. PVAP, CAP and Ratio of Eudragit L 100:
Eudragit S 100 was used as pH dependent polymer for coating the
core tablets. Total 9 batches were formulated as per 32 full
factorial design applied to check the effect of polymer ratio
(Eudragit L 100: Eudragit S 100) and the effect of % weight gain on
dependent variable lag time PRTs. These formulations were evaluated
for physical parameters of tablet, drug -excipient compatibility
study, lag time of rupture of PRTs and in-vitro drug release study.
PDDS of Montelukast Sodium formulated using Croscarmellose sodium
as super disintegrant and Eudragit L 100 and Eudragit S 100 as a
coating polymers. Formulation M7 can provide site specific delivery
with sigmoidal drug release.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!